Retusin
CAS No. 1245-15-4
Retusin( —— )
Catalog No. M29223 CAS No. 1245-15-4
Retusin is derived from the leaves of Talinum triangulare. Retusin Retusin can be used in studies about acting as pre- and postemergent herbicides.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 176 | In Stock |
|
| 10MG | 302 | In Stock |
|
| 25MG | 506 | In Stock |
|
| 50MG | 706 | In Stock |
|
| 100MG | Get Quote | In Stock |
|
| 200MG | Get Quote | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameRetusin
-
NoteResearch use only, not for human use.
-
Brief DescriptionRetusin is derived from the leaves of Talinum triangulare. Retusin Retusin can be used in studies about acting as pre- and postemergent herbicides.
-
DescriptionRetusin is derived from the leaves of Talinum triangulare. Retusin Retusin can be used in studies about acting as pre- and postemergent herbicides.(In Vitro):Retusin exhibits potent free-radical-scavenging capacities. Retusin inhibits both cellular melanin formation and antityrosinase activity in B16F10 melanocytes.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayEndocrinology/Hormones
-
TargetATPase
-
RecptorATPase
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number1245-15-4
-
Formula Weight358.346
-
Molecular FormulaC19H18O7
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 25 mg/mL (69.77 mM)
-
SMILESCOc1cc(O)c2c(c1)oc(-c1ccc(OC)c(OC)c1)c(OC)c2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Gboxin
Gboxin is a small molecule that specifically inhibits the growth of primary mouse and human glioblastoma cells (primary GBM IC50=150 nM).
-
Wilforine
Wilforine is a sesquiterpene pyridine alkaloid; important bioactive compound in T. wilfordii plants and is effective in treating idiopathic pulmonary fibrosis.
-
NDI-091143
NDI-091143 is a potent and high-affinity human ATP-citrate lyase (ACLY) inhibitor with an IC50 of 2.1 nM (ADP-Glo assay)indirectly disrupting citrate binding via an unexpected mechanism of inhibition.
Cart
sales@molnova.com